U.S. President Joe Biden on Aug. 3 urged Republican leaders in Florida and Texas – home to roughly a third of all new U.S. Covid-19 cases – to follow public health guidelines on the pandemic or “get out of the way” as the country struggles to contain the rapid spread of the disease’s Delta variant.
If you are not happy with the results below please do another search
50 search results for:
The U.S. Food and Drug Administration is aiming to give full approval for the Pfizer vaccine by early September, the New York Times reported on Aug. 3, citing people involved in the effort.
Topline results from Outlook Therapeutics’ pivotal Phase III NORSE TWO safety and efficacy trial show the biopharmaceutical company’s ONS-5010/Lytenava (bevacizumab) significantly improved outcomes in patients with neovascular age-related macular degeneration.
New York City will become the first major U.S. city to require proof of Covid-19 vaccination for customers and staff at restaurants, gyms and other indoor businesses as the country enters a new phase of battling the highly contagious Delta variant.
Sage Therapeutics ended two late-stage studies of the depression drug zuranolone after discussions with the U.S. Food and Drug Administration led the company to believe they were unnecessary for potential regulatory approval.
Bristol Myers Squibb is withdrawing the biopharmaceutical giant’s Istodax from the market after recent trials showed that the peripheral T-cell lymphoma drug did not achieve primary efficacy endpoint.
Ashfield Health, a global healthcare marketing and communications network and part of UDG Healthcare, launched GRAVITYai, a global healthcare intelligence data platform. The data solution is designed to support pharma, life science, biotech and other healthcare partners to work faster, better and more efficiently across every stage of the product life cycle.
Eli Lilly is in the news for positive Olumiant data in Covid-19, a drop in Covid-19 product sales for second-quarter 2021, and a protest of one of the company’s ads.
Healthcare advertising agency PRECISIONeffect acquired Pascāle, an international healthcare communications company specializing in public relations and social media.
Sanofi agreed to buy U.S. biotech company Translate Bio in a $3.2 billion deal, as the French pharmaceuticals firm bets on next-generation mRNA vaccine technology beyond the Covid-19 pandemic, confirming a Reuters exclusive report.